Literature DB >> 18325061

Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction.

Jörg Simon1, Rainer Kuefer, Georg Bartsch, Björn G Volkmer, Richard E Hautmann, Hans-Werner Gottfried.   

Abstract

OBJECTIVE: To report the results using an extensive saturation biopsy in men with negative prostate biopsies but in whom there is still a clinical suspicion for carcinoma. PATIENTS AND METHODS: Between February 1999 and October 2004 we offered 40 patients (median age 63 years) an extensive saturation biopsy if there was clinical suspicion of prostate cancer after previous negative prostate biopsies. The median (range) number of cores taken was 64 (39-139) and was adjusted to the size of the prostate. All patients received general or spinal anaesthesia.
RESULTS: Of the 40 patients, 18 (45%) had carcinoma in at least one core; 16 had a radical prostatectomy, which showed pT2a, pT2b, pT2c, pT3a and pT3b adenocarcinoma of the prostate in three, four, six, two and one patients, respectively. Brachytherapy and external radiation were the therapies of choice in the other patients. Sixteen patients had marked haematuria after the biopsy procedure.
CONCLUSION: There is no significant increase in the cancer detection rate in an extensive saturation-biopsy regimen compared to published series with fewer cores, but the morbidity increased.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325061     DOI: 10.1111/j.1464-410X.2008.07560.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  18 in total

Review 1.  [Multiparametric MRI, elastography, contrastenhanced TRUS. Are there indications with reliable diagnostic advantages before prostate biopsy?].

Authors:  A Hegele; L Skrobek; R Hofmann; P Olbert
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 2.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

3.  There is no role for focal therapy in prostate cancer.

Authors:  Peter Black
Journal:  Can Urol Assoc J       Date:  2009-08       Impact factor: 1.862

4.  Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?

Authors:  L Schimmöller; M Quentin; D Blondin; F Dietzel; A Hiester; C Schleich; C Thomas; R Rabenalt; H E Gabbert; P Albers; G Antoch; C Arsov
Journal:  Eur Radiol       Date:  2016-02-26       Impact factor: 5.315

5.  Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China.

Authors:  Qing Zhang; Wei Wang; Rong Yang; Gutian Zhang; Bing Zhang; Weiping Li; Haifeng Huang; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2015-03-29       Impact factor: 2.370

6.  Prostate cancer diagnostics: innovative imaging in case of multiple negative biopsies.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2011-07-09       Impact factor: 4.226

Review 7.  Random biopsy: when, how many and where to take the cores?

Authors:  Vincenzo Scattoni; Carmen Maccagnano; Umberto Capitanio; Andrea Gallina; Alberto Briganti; Francesco Montorsi
Journal:  World J Urol       Date:  2014-06-08       Impact factor: 4.226

8.  Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies.

Authors:  Bjoern Grabski; Leif Baeurle; Annemie Loch; Bjoern Wefer; Udo Paul; Tillmann Loch
Journal:  World J Urol       Date:  2011-06-21       Impact factor: 4.226

Review 9.  Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy.

Authors:  Geoffrey A Sonn; Daniel J Margolis; Leonard S Marks
Journal:  Urol Oncol       Date:  2013-11-13       Impact factor: 3.498

10.  Patients with Persistently Elevated PSA and Negative Results of TRUS-Biopsy: Does 6-Month Treatment with Dutasteride can Indicate Candidates for Re-Biopsy. What is the Best of Saturation Schemes: Transrectal or Transperineal Approach?

Authors:  Sergey Kravchick; Leonid Lobik; Shmuel Cytron; Yakov Kravchenko; David Ben Dor; Ronit Peled
Journal:  Pathol Oncol Res       Date:  2015-03-10       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.